Equities

Monte Rosa Therapeutics Inc

GLUE:NSQ

Monte Rosa Therapeutics Inc

Actions
  • Price (USD)8.49
  • Today's Change0.14 / 1.68%
  • Shares traded369.98k
  • 1 Year change+184.90%
  • Beta1.2740
Data delayed at least 15 minutes, as of Nov 22 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, Monte Rosa Therapeutics Inc increased its cash reserves by 120.44%, or 72.49m. Cash Flow from Investing totalled 88.80m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 43.80m for operations while cash generated from financing totalled 27.49m.
Cash flow per share-1.65
Price/Cash flow per share--
Book value per share3.35
Tangible book value per share3.35
More ▼

Balance sheet in USDView more

Monte Rosa Therapeutics Inc has a strong Balance Sheet and has consistently grown its cash reserves over the last Four years to total 128.10m.
Current ratio6.03
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.